Wrap Text
ASPI announces collaboration between QLE and University of Bristol to design advanced laser research facility
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
ASPI ANNOUNCES STRATEGIC COLLABORATION BETWEEN QUANTUM LEAP ENERGY AND
UNIVERSITY OF BRISTOL TO DESIGN ADVANCED LASER RESEARCH FACILITY
Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK
DALLAS, March 24, 2026 -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASPI") today announced that a UK
subsidiary of Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of ASPI dedicated to
advancing innovative technologies and processes across critical segments of the fission and fusion nuclear
fuel cycle, has commenced a strategic collaboration with the University of Bristol for the design of a state-
of-the-art lithium laser research facility in the UK. This collaboration marks a significant milestone in QLE's
commercial strategy to meet rapidly growing market demand for advanced nuclear fuels.
Under the terms of the agreement, the University of Bristol will lead the design and feasibility study for a
site-agnostic laser enrichment research facility over an estimated four-month initial phase. The project
involves comprehensive desk-based concept design work, detailed engineering specifications, and safety
reviews to establish the foundation for what could become a groundbreaking research hub.
"This collaboration with the University of Bristol represents a pivotal step forward in our mission to advance
nuclear fuel technology," said Dr Ryno Pretorius, CEO of Quantum Leap Energy LLC. "Bristol University's
world-class expertise in research facility design, coupled with their team's deep understanding of lithium
and critical elements in nuclear technology make them an ideal partner for this ambitious project."
The University of Bristol will coordinate a comprehensive team of specialists, including experts in
mechanical, electrical, and plumbing specification, structural engineering, architecture, construction project
management, pyrophoric lithium handling, and laser safety. The project will progress through multiple
phases, including documentation review, safety assessments, cell design development, and detailed facility
design work culminating in RIBA Stage 4 (Technical Design) completion.
Subject to a positive feasibility assessment, the parties intend to proceed with construction of the facility at
a suitable University of Bristol site off-campus where it will enable cutting-edge research commissioned and
funded by QLE.
QLE's UK program of work has been developed in consultation with key UK government and regulatory
bodies, including the Department for Energy Security and Net Zero, the UK Atomic Energy Authority, the
Office for Nuclear Regulation, and the Environment Agency, demonstrating QLE's commitment to the
highest standards of safety, security and regulatory compliance.
The new collaboration underscores QLE's strategic focus on building partnerships with leading academic
institutions to advance technological capabilities that address the rapidly growing market demand for
advanced nuclear fuel components. While enriched lithium-6 (?Li) is essential for fusion reactors' breeding
systems, requiring enrichment levels of 60-90% compared to natural lithium's 7.5% ?Li content, lithium-7
(?Li) also plays a critical role in some existing and next-generation fission technologies. The QE technology,
originally developed for uranium isotope separation, leverages quantum mechanical principles to achieve
isotopic separation with several compelling advantages over existing methods and represents a unique
strategic opportunity that could redefine nuclear energy supply economics.
About Quantum Leap Energy
Quantum Leap Energy is a development stage nuclear fuels company dedicated to advancing innovative
technologies and processes across critical segments of the nuclear fuel cycle. The Company focuses on
both front-end activities, including uranium conversion, enrichment of uranium-235 for nuclear fuel
production (HALEU, LEU+ and LEU), and isotopic separation of lithium-6 and lithium-7, as well as back-
end radioactive waste treatment technologies. Through exclusive global rights to proprietary Aerodynamic
Separation Process (ASP) and laser-based Quantum Enrichment (QE) technologies, Quantum Leap
Energy aims to address gaps in the nuclear fuel supply chain for advanced nuclear reactors, small modular
reactors, and fusion systems. The Company has established strategic partnerships with industry leaders
including TerraPower, Fermi America, and the South Africa Nuclear Energy Corporation (Necsa) to
accelerate the commercialization of critical isotopes essential for next-generation nuclear energy systems.
For additional information, please visit: https://www.qleapenergy.com/.
About ASP Isotopes Inc.
ASP Isotopes is developing a differentiated isotope enrichment platform to strengthen global supply chain
access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy.
The Company's proprietary technologies, the Aerodynamic Separation Process ("ASP technology") and
Quantum Enrichment ("QE technology"), are designed to enable the production of isotopes for a range of
industrial and advanced technology applications. ASP Isotopes operates isotope enrichment facilities in
Pretoria, South Africa, focused on the enrichment of low atomic mass elements, or light isotopes. For more
information, please visit www.aspisotopes.com.
Forward-Looking Statements
Statements contained herein relating to future plans, results, performance, expectations, achievements and
the like are considered "forward-looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements include, but are not limited to, the outcome of the
collaboration with Bristol University, the commencement of research, development and production activities
in the United Kingdom, the future of the company's enrichment technologies as applied to lithium
enrichment, the outcome of the company's initiative to commence enrichment of lithium in the UK and the
company's discussions with nuclear regulators in the UK, QLE's anticipated growth strategies and
anticipated trends in QLE's business, statements related to the anticipated benefits to QLE and the
collaboration resulting from the research agreement discussed herein, and statements we make regarding
expected operating results, such as future revenues and prospects from the potential commercialization of
isotopes, future performance under contracts, and our strategies for product development, engaging with
potential customers, market position, and financial results. These forward-looking statements involve
known and unknown risks, uncertainties, and other factors, many of which may be beyond QLE's or ASPI's
control, that may cause actual results to differ materially from any future results, performance or
achievements expressed or implied by any forward-looking statements. All forward-looking statements
speak only as of the date hereof. QLE and ASPI undertake no obligation to revise or update any forward-
looking statements except as may be required by applicable law.
Contact
QLE@icrinc.com
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
24 March 2026
Sponsor
Valeo Capital Proprietary Limited
Date: 24-03-2026 01:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
